ESGCT: Our extensive Peptide Ressources for Gene Therapy
Published on 06/10/2022
Adenoviruses and Adeno-associated viruses can be used as powerful gene delivery vehicles for the development of vaccines and gene therapy to treat conditions for instance cystic fibrosis, immunodeficiencies (X-SCID), and hematological disorders such as haemophilia and thalassemia. The upcoming annual meeting of the European Society of Gene and Cell Therapy (ESGCT) taking place October 11th-14th is dedicated to this novelizing cutting-edge technologies and our European Business Development team (Dr. Michael Drosch & Gregory Hansen, PhD) are happy to participate in this meeting.
In light of this upcoming event we would like to raise your attention on our PepMix Peptide Pools and PepStar Peptide-Arrays directed against:
PepMix
- Adeno-Associated Virus 5 (Capsid)
- Adeno-Associated Virus 6 (Capsid VP1)
- Adeno-Associated Virus 8 (Capsid)
- Human Adenovirus 3 (Hexon)
- Human Adenovirus 5 (Penton)
- Human Adenovirus 5 (Hexon)
- Human Adenovirus 26 (Penton)
- Human Adenovirus 26 (Hexon)
- Chimpanzee Adenovirus Y25 (Penton)
- Chimpanzee Adenovirus Y25 (Hexon)
- Human Adenovirus 3 (Hexon)
- Human Adenovirus 5 (Penton)
- Human Adenovirus 26 (Penton & Hexon)
- Chimpanzee Adenovirus Y25 (Penton & Hexon)
These tools facilitate to detect and monitor the anti-vector T and B-cells' immune response as a crucial part of therapy development.
Beyond our extensive catalog resources, please consider our custom peptide options. As the provider of the largest variety of custom peptide formats, we will make it our mission to work with you and design the best peptide tools specific to your research needs.
We will be happy to personally discuss your project requirements. Meet us at ESGCT at booth 53, or just contact us, or reach out to our customer support team.